SPEAR T-cells Derived from Stem Cells Kill Cancer Targets in vitro - data from ASGCT 2020

Adaptimmune SPEAR T-Cell Mechanism of Action VideoПодробнее

SPEARHEAD-2 trial design: combining SPEAR T-cells with pembrolizumabПодробнее

Adaptimmune: SPEAR T-cellsПодробнее

SURPASS: evaluating the next-generation of SPEAR T-cell therapyПодробнее

Jonathan Silk: Next Generation approaches to enhance the efficacy of SPEAR T-cellsПодробнее

Reprogramming Human T Cell Circuitry - Alexander MarsonПодробнее

CAR-T Cells: Poseida Therapeutics - Matt SpearПодробнее

How Cancer Patients get Treated with our SPEAR T-CellsПодробнее

Adaptimmune ASGCT 2021Подробнее

Activated T cell attacks a cancer cellПодробнее

AdaptimmuneПодробнее

CAR T-cell Therapy VideoПодробнее

Embroynic Stem Cells Derived T Cells | Protocol PreviewПодробнее

Engineered T cells for Cancer Therapy in 2018 - Saar GillПодробнее

Label-free Live Cell Imaging: Activated T-Cell Killing Cancer CellПодробнее

SITC 2020 - Adaptimmune's SURPASS PosterПодробнее

Engineered iPSC-derived Lymphocytes for Improved Cancer TherapyПодробнее

How Our SPEAR T-cells WorkПодробнее